Skip to main content

Table 1 Positive results in serological and real-time PCR assays are shown in bold

From: Diagnosis of HEV infection by serological and real-time PCR assays: a study on acute non-A-C hepatitis collected from 2004 to 2010 in Italy

Patient code

Results of serological assaysa

Results of real-time PCR (HEV-RNAb)

HEV genotype

Country of origin *

ALT (UI/L)

Bioelisa HEV - IgM

Bioelisa HEV - IgG

8

>3.000

>3.000

+ + +

1a

Italy (India)

2640

3

1.304

>3.000

+ + +

1a

Bangladesh

1726

12

>3.000

>3.000

+ + +

 

India

1072

39

0.882

>3.000

+ + +

 

India

2463

16

1.801

>3.000

+ +

1a

Bangladesh

1263

19

1.695

>3.000

+ +

 

Bangladesh

835

22

>3.000

>3.000

+ +

1a

Italy (India)

n.a.

43

0.508

>3.000

+ +

 

Bangladesh

4515

47

0.867

>3.000

+ +

 

Bangladesh

1683

48

2.709

>3.000

+ +

 

Bangladesh

2050

52

0.869

>3.000

+ +

1a

Bangladesh

2496

55

1.316

>3.000

+ +

 

India

1263

56

1.508

>3.000

+ +

 

Bangladesh

n.a.

58

0.793

2.070

+ +

 

Italy (Thailand)

4044

60

2.665

0.775

+ +

3e

Italy

2010

7

0.498

>3.000

+ +

 

India

486

51

>3.000

>3.000

+ +

 

Italy

n.a.

61

0.630

1.972

+ +

1a

Italy (India)

2472

10

2.388

>3.000

+

 

Ethiopia

5328

29

2.212

>3.000

+

 

Bangladesh

n.a.

34

>3.000

2.969

+

 

Italy

855

63

0.102

0.088

+ + +

 

Albania

597

33°

0.057

1.354

+

 

Italy

384

20°

0.653

0.151

-

 

Italy (Africa)

over

30°

2.986

0.336

-

 

Pakistan

n.a.

50°

0.480

0.081

-

 

Italy

3860

67°

0.546

0.000

-

 

Italy (Africa)

842

26°

0.271

0.814

-

 

n.a.

2050

28°

0.062

0.709

-

 

Bangladesh

806

32°

0.126

1.226

-

 

Italy

2391

  1. a Bioelisa HEV IgM, (cut-off = 0.421); Bioelisa HEV IgG, (cut-off = 0.574); Biokit.
  2. b +: 250 < copies/mL < 2,500; + +: 2,500 < copies/mL <25,000; + + +: >25,000 copies/mL; -: < 250 copies/mL.
  3. * All foreign patients either arrived in Italy or travelled to their country of origin less than one month before the onset of clinical symptoms. Travel to countries from endemic areas are indicated in brackets for Italian patients.
  4. n.a. : not available.
  5. °Serum was also analysed with HEV IgM Elisa MP Diagnostics (cut-off = 0.403); HEV IgM Elisa Wantai Biopharm (cut-off = 0.263). All samples were negative except sample 33 which showed OD values of 0.421 and 0.334 in MP Diagnostic and Wantai Biopharm assays, respectively.